Results 251 to 260 of about 211,077 (381)
Prediabetes and cerebral small vessel disease [PDF]
H. Mo+4 more
openaire +2 more sources
Human Organoids and Their Application in Tumor Models, Disease Modeling, and Tissue Engineering
ABSTRACT Organoid technology has revolutionized biomedical research, disease modeling, drug discovery, and regenerative medicine by providing three‐dimensional (3D) organ‐like structures that closely mimic native human tissues. Derived from pluripotent and adult stem cells, organoids replicate the structural, cellular, and functional characteristics of
Siyuan Song, Zheng Liu, Yi Wang, Bo Gong
wiley +1 more source
Detecting the fractal physical activity pattern in aged adults with cerebral small vessel disease. [PDF]
Zhào H, Wei W, Lv F, Shen J, Huang Y.
europepmc +1 more source
[P3-248]: PLASMA AMYLOID BETA LEVELS, CEREBRAL SMALL-VESSEL DISEASES AND COGNITION: THE ROTTERDAM STUDY [PDF]
Saima Hilal+7 more
openalex +1 more source
Abstract Background The aim was to investigate if glymphatic function is impaired in patients with Huntington's disease (HD) and its clinical relevance. Methods Forty‐nine subjects carrying mutant Huntingtin (mHTT), comprising 35 manifest (mHD) and 14 pre‐manifest (PreHD), and 35 healthy controls (HC) were recruited in this study.
Jin‐Hui Yin+3 more
wiley +1 more source
Loss of Venous Integrity in Cerebral Small Vessel Disease
François De Guio+6 more
openalex +1 more source
Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage [PDF]
Grégoire Boulouis+13 more
openalex +1 more source
Cholinergic System Changes in Dopa‐Unresponsive Freezing of Gait in Parkinson's Disease
Abstract Background Freezing of gait (FoG) is a debilitating mobility disturbance that becomes increasingly resistant to dopaminergic pharmacotherapies with advancing Parkinson's disease (PD). The pathophysiology underlying the response of FoG to dopaminergic treatment is poorly understood.
Kelvin L. Chou+6 more
wiley +1 more source
Cortical microstructural involvement in cerebral small vessel disease
Background: In cerebral small vessel disease (CSVD), cortical atrophy occurs at a later stage compared to microstructural abnormalities and therefore cannot be used for monitoring short-term disease progression.
Annemarie Reiländer+7 more
doaj